Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
University College, London
With
This study aimed to investigate the effect of maintenance pembrolizumab in patients who underwent treatment with weekly paclitaxel for platinum-resistant recurrent ovarian cancer and either responded or progressed after a minimum of 4 cycles of treatment. Participants were enrolled to receive 3 weekly pembrolizumab until progression. This was a non-randomised phase II study, and the population may be different from those who received paclitaxel and bevacizumab.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
